Preclinical Data Support Remyelinating Potential of ABX-002 & Seasonal Adjustments and MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge discusses how ABX-002, Autobahn Therapeutics' experimental treatment for multiple sclerosis, promoted restoration of the myelin sheath.
He also reads “It’s Time to Start Thinking About Seasonal Adjustments and MS" by Beth Ullah, from her column "Through the Looking Glass."

===================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/